Admera Health Teams with Allure Specialty Pharmacy to Offer PharmD Fellowship Program
South Plainfield, NJ – September 25, 2018 - Today, Admera Health, a molecular diagnostics company, in conjunction with Allure Specialty Pharmacy announced the launch of a Post-Doctoral PharmD Fellowship Program focused on pharmacogenomics. The Admera Health-Allure Specialty Pharmacy Program is a multi-site fellowship program that includes two longitudinal experiences [...]
Quadrant Biosciences Partners with Leading Edge Genomic Testing Company Admera Health
SYRACUSE, N.Y., Aug. 8, 2018 /PRNewswire/ — Quadrant Biosciences Inc., an emerging life science company based in Syracuse, New York, is pleased to announce its strategic partnership with Admera Health, an advanced molecular diagnostics company headquartered in South Plainfield, NJ. The partnership brings together two companies that have been identified as innovators within [...]
Admera Health Announces Availability of Psychiatric Specific Report, PGxPsych™, for its PGxOne™ Plus Pharmacogenomics Test
South Plainfield, NJ – June 26, 2018 - Today, Admera Health (www.admerahealth.com), announced the availability of a psychiatric specific report for its PGxOne™ Plus pharmacogenomics test. PGxOne™ Plus is a laboratory developed test that includes over 50 genes, over 200 DNA variants (affecting drug metabolism, transportation, and activation), and provides [...]
Admera Health Launches New Tests for Cancer Supportive Care and Liquid Biopsy, Now Provides a Comprehensive Portfolio of Oncology Products
SOUTH PLAINFIELD, N.J., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health (www.admerahealth.com) announced the launch of multiple laboratory developed tests: PGxOnco™, for cancer supportive care, and LiquidGx™, a suite of liquid biopsy based tests for tumor profiling and drug resistance monitoring. Admera initially unveiled these tests on October [...]
Admera Health Expands Asian Footprint with Three Strategic Partnerships
South Plainfield, NJ – September 12, 2017 – Today, Admera Health announced agreements expanding Admera’s portfolio of molecular diagnostics to Asia, including but not limited to Singapore, Hong Kong, Korea and Taiwan. Admera Health, a molecular diagnostic company, offers the most comprehensive pharmacogenomics testing services available, its PGxOne™ Plus [...]